Better questions.
Informed decisions.
Myth: fatigue automatically means low testosterone.
Fatigue and changes in libido or concentration can occur with testosterone deficiency, but also with other health concerns. A symptom checklist cannot diagnose the cause. Evaluation for low testosterone generally includes compatible symptoms and repeat early-morning measurements.
Before a visit, note when symptoms began, sleep patterns, current medications, and the changes that matter most to you.
Myth: “bioidentical” always means safer.
The term describes hormones with the same molecular structure as hormones made by the body. It is not a safety certification. FDA-approved bioidentical products exist; custom-compounded formulations are a separate category.
ACOG recommends FDA-approved menopausal hormone products over compounded preparations when approved options are available. Compounded products are not FDA-approved and may have additional dose and quality concerns.
Myth: a modern delivery method removes every risk.
Pills, patches, gels, and other formulations differ. Route can affect certain risks, but no route makes a medication appropriate for everyone. Choice depends on the specific product, symptoms, medical history, and monitoring.
For menopause symptoms, ask about hormonal and nonhormonal choices. Discuss age, time since menopause, cancer history, blood clot history, and whether systemic or local treatment fits the concern.
General education only. A clinician must assess your individual circumstances. Clinic service availability should be confirmed when scheduling.